Smoking- and menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptoms

Addictive Behaviors

Volumn 39, Issue 5, 2014, Pages 901-906

  Allen, Sharon S ^a   Allen, Alicia M ^a   Tosun, Nicole ^a   Lunos, Scott ^a   al'Absi, Mustafa ^b   Hatsukami, Dorothy ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Depressive symptoms; Menstrual cycle; Smoking cessation; Withdrawal

Indexed keywords

ADULT; ARTICLE; CROSSOVER PROCEDURE; DEPRESSION; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FOLLICULAR PHASE; FOLLOW UP; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; STRESS; SYMPTOMATOLOGY; TOBACCO DEPENDENCE; YOUNG ADULT; ADOLESCENT; CONTROLLED STUDY; MENSTRUATION DISTURBANCES; PHYSIOLOGY; PSYCHOLOGY; SUBSTANCE WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; CROSS-OVER STUDIES; DEPRESSION; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84896821739     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2014.01.029     Document Type: Article

References (62)

1. Allen A., al'Absi M., Lando H., Hatsukami D., Allen S. Menstrual phase, depressive symptoms, and Allopregnanolone during short-term smoking cessation. Experimental Clinical Psychopharmacology 2013, 21(6):427-433.
2. Allen S., Allen A., Kotlyar M., Lunos S., Al'absi M., Hatsukami D. Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence. Nicotine & Tobacco Research 2012, 15(6):1091-1098.
3. Allen A., Allen S., Lunos S., Pomerleau C. Severity of withdrawal symptomatology in follicular versus luteal quitters: The combined effects of menstrual phase and withdrawal on smoking cessation outcome. Addictive Behaviors 2010, 35(6):549-552.
4. Allen S., Bade T., Center B., Finstad D., Hatsukami D. Menstrual phase effects on smoking relapse. Addiction 2008, 103:809-821.
5. Allen S., Hatsukami D., Christianson D., Brown S. Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle. Nicotine & Tobacco Research 2000, 2:231-241.
6. Allen S., Hatsukami D., Christianson D., Nelson D. Withdrawal and pre-menstrual symptomatology during the menstrual cycle in short-term smoking abstinence: effects of menstrual cycle on smoking abstinence. Nicotine & Tobacco Research 1999, 1:129-142.
7. Allen S., McBride C., Pirie P. The shortened premenstrual assessment form. Journal of Reproductive Medicine 1991, 36(11):769-772.
8. Borrelli B., Marcus B., Clark M., Bock B., King T.K., Roberts M. History of depression and subsyndromal depression in women smokers. Addictive Behaviors 1999, 24(6):781-794.
9. Carpenter M., Saladin M., Leinbach A., LaRowe S., Upadhyaya H. Menstrual phase effects on smoking cessation: A pilot feasibility study. Journal of Women's Health 2008, 17(2):293-301.
10. Carpenter M., Upadhyaya H., LaRowe S., Saladin M., Brady K. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: A Review. Nicotine & Tobacco Research 2006, 8(5):627-638.
11. Carroll M., Anker J. Sex differences and ovarian hormones in animal models of drug dependence. Hormones and Behavior 2010, 58:44-56.
12. Centers for Disease Control, Prevention Current cigarette smoking among adults - United States, 2011. Morbidity and Mortality Weekly Report 2012, 61(44):889-894. (accessed 2013 June 5).
13. Cepeda-Benito A., Reynoso J.T., Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. Journal of Consulting and Clinical Psychology 2004, 72(4):712-722.
14. Cohen S., Kamarch T., Mermelstein R. A global measure of perceived stress. Journal of Health and Social Behavior 1983, 24:385-396.
15. Craig D., Parrott A., Coomber J. Smoking cessation in women: Effects of the menstrual cycle. International Journal of Mental Health and Addiction 1992, 27(6):697-706.
16. Deecher D., Andree T., Sloan D., Schechter L. From menarche to menopause: Exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008, 33:3-17.
17. Dierker L., Avenevoli S., Stolar M., Merikangas K. Smoking and depression: An examination of mechanisms of comorbidity. American Journal of Psychiatry 2002, 159:947-953.
18. Donny E., Caggiula A., Rowell P., Gharib M., Maldovan V., Booth S., et al. Nicotine self-administration in rats: Estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology 2000, 151:392-405.
19. Egervari L., Csala I., Dome P., Faludi G., Lazary J. P-21 - The role of depressive phenotype in smoking cessation. European Psychiatry 2012, 27:1.
20. Franklin T.R., Ehrman R., Lynch K.G., Harper D., Sciortino N., O'Brien C.P., et al. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: A retrospective analysis. Journal of Women's Health 2008, 17(2):287-292.
21. Goletiani N., Siegel A., Hudson J. The effects of smoked nicotine on behavioral measures/mood states and hypothalamic-pituitary-adrenal axis hormones in women during the follicular and luteal phases of the menstrual cycle. Presented at the College on Problems of Drug Dependence (CPDD) 74th Annual meeting 2012.
22. Harvey A., Hitchcock C., Prior J. Ovulation disturbances and mood across the menstrual cycles of healthy women. Journal of Psychosomatic Obstetrics and Gynecology 2009, 30(4):207-214.
23. Heatherton T., Kozlowski L., Frecker R., Fagerstrom K. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction 1991, 86:1119-1127.
24. Holma I., Holma K., Melartine T., Ketokivi M., Isometsä E.T. Depression and smoking: A 5-year prospective study of patients with major depressive disorder. Depression and Anxiety 2013, 30:580-588.
25. Hughes J., Hatsukami D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 1986, 43:289-294.
26. Hughes J., Hatsukami D. Errors in using tobacco withdrawal scale. Tobacco Control 1998, 7:92-93.
27. Kassel J., Stroud L., Paronis C. Smoking, stress and negative affect: Correlation, causation, and content across stages of smoking. Psychological Bulletin 2003, 129(2):270-304.
28. King A., de Wit H., Riley R., Cao D., Niaura R., Hatsukami D. Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences. Nicotine & Tobacco Research 2006, 8(5):671-682.
29. Klier C.M., Muzik M., Dervic K., Mossaheb N., Benesch T., Ulm B., et al. The role of estrogen and progesterone in depression after birth. Journal of Psychiatric Research 2007, 41:273-279.
30. Kroenke K., Spitzer R., Williams J. The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine 2001, 16:606-613.
31. Langdon K., Leventhal A., Stewart S., Rosenfield D., Steeves D., Zvolensky M.J. Anhedonia and anxiety sensitivity: Prospective relationships to nicotine withdrawal symptoms during smoking cessation. Journal of Studies on Alcohol and Drugs 2013, 74(3):469-478.
32. Lynch W. Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats. Pharmacology Biochemistry and Behavior 2009, 94:43-50.
33. Lynch W., Sofuoglu M. Role of progesterone in nicotine addiction: Evidence from initiation to relapse. Experimental and Clinical Psychopharmacology 2010, 18(6):451-461.
34. Marks J., Pomerleau C., Pomerleau O. Effects of menstrual phase on reactivity to nicotine. Addictive Behaviors 1999, 24:127-134.
35. Masson C., Gilvert D. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive user and nonusers. Journal of Behavioral Medicine 1999, 22:589-604.
36. Mazure C., Toll B., McKee S., Wu R., O'Malley S. Menstrual cycle phase at quit date and smoking abstinence at 6weeks in an open label trial of bupropion. Drug and Alcohol Dependence 2011, 114:68-72.
37. Michal M., Wiltink J., Reiner I., Kirschner Y., Wild P.S., Schulz A., et al. Association of mental distress with smoking status in the community: Results from the Gutenberg health Study. Journal of Affective Disorders 2013, 146(3):355-360.
38. Nakajima M., al'Absi M. Predictors of risk for smoking relapse in men and women: A prospective examination. Psychology of Addictive Behaviors 2012, 26(3):633-637.
39. Natale V., Albertazzi P. Mood swings across the menstrual cycle: A comparison between oral contraceptive users and non-users. Biological Rhythm Research 2006, 37(6):489-495.
40. Niaura R., Britt D., Shadel W., Goldstein M., Abrams D., Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychology of Addictive Behaviors 2001, 15(1):13-17.
41. O'Hara P., Portser S., Anderson B. The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addictive Behaviors 1989, 14(6):595-600.
42. Paperwalla K., Levin T., Weiner J., Saravay S. Smoking and depression. Medical Clinics of North America 2004, 88(6):1483-1494.
43. Pergadia M., Agrawal A., Heath A., Martin N., Bucholz K.K., Madden P.A. Nicotine withdrawal symptoms in adolescent and adult twins. Twin Research and Human Genetics 2010, 13(4):359-369.
44. Perkins K. Smoking cessation in women. Special considerations. CNS Drugs 2001, 15(5):391-411.
45. Perkins K., Levine M., Marcus M., Shiffman S., D'Amico D., Miller A., et al. Tobacco withdrawal in women and menstrual cycle phase. Journal of Consulting and Clinical Psychology 2000, 68:176-180.
46. Pomerleau C., Garcia A., Pomerleau O., Cameron O. The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: A preliminary report. Psychoneuroendocrinology 1992, 17(6):627-638.
47. Pomerleau C., Mehringer A., Marks J., Downey K., Pomerleau O. Effects of menstrual phase and smoking abstinence in smokers with and without a history of major depressive disorder. Addictive Behaviors 2000, 25:483-497.
48. Radloff l. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1977, 1:385-401.
49. Rundmo T., Smedslund G., Gotestam K. Expectancies of and specific attitudes towards smoking as predictors of general attitude about smoking. Psychological Reports 1997, 81(3):1175-1185.
50. Ryan J., Burger H.G., Szoeke C., Lehert P., Ancelin M.L., Henderson V.W., et al. A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Menopause 2009, 16(3):509-517.
51. Scarinci I., Thomas J., Brantley P., Jones G. Examination of the temporal relationship between smoking and major depressive disorder among low-income women in public primary care clinics. American Journal of Health Promotion 2002, 16(6):323-330.
52. Scharf D., Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR. Addiction 2004, 99:1462-1469.
53. Schnoll R., Leone F., Hitsman B. Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch. Journal of Addictive Disease 2013, 32(1):46-52.
54. Snively T., Ahijevych K., Bernhard L., Wewers M. Smoking behavior, dysphoric states and the menstrual cycle: Results from the single smoking sessions and the natural environment. Psychoneuroendocrinology 2000, 25:677-691.
55. Sofuoglu M., Mouratidis M., Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology 2010, 36:123-132.
56. Tiffany S., Drobes D. The development and initial validation of a questionnaire on smoking urges. Brittish Journal of Addiction 1991, 86(1):1467-1476.
57. U.S.Department of Health and Human Services Women and smoking: A report of the surgeon general 2001, U.S. Department of Health and Human Services, Atlanta, GA.
58. Watson D., Clark L., Carey G. Positive and negative affectivity and their relation to anxiety and depressive disorders. Journal of Abnormal Psychology 1988, 97(3):346-353.
59. Weinberger A., McKee S. Gender differences in smoking following an implicit mood induction. Nicotine & Tobacco Research 2011, 14(5):621-625.
60. Wewers M.E., Salsberry P.J., Ferketich A.K., Ahijevych K.L., Hood N.E., Paskett E.D. Risk factors for smoking in rural women. Journal of Women's Health 2012, 21(5):548-556.
61. Wiesbeck G., Kuhl H., Yaldizli O., Wurstet F. Tobacco smoking and depression - Results from the WHO/ISBRA Study. Neuropsychobiology 2008, 57:26-31.
62. Wittchen H.U., Kessler R.C., Ustun T.B. Properties of the Composite International Diagnostic Interview (CIDI) for measuring mental health outcome. Mental Health Outcome Measures 2001, 212-227. 2nd ed. G. Thornicroft, M. Tansella (Eds.).